Resistance to endotoxic shock in mice lacking natriuretic peptide receptor-A.

British Journal of Pharmacology
Catherine M PanayiotouAdrian J Hobbs

Abstract

Excessive production of nitric oxide (NO) by inducible NO synthase (iNOS) is thought to underlie the vascular dysfunction, systemic hypotension and organ failure that characterize endotoxic shock. Plasma levels of atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP) and C-type natriuretic peptide (CNP) are raised in animal models and humans with endotoxic shock and correlate with the associated cardiovascular dysfunction. Since both NO and natriuretic peptides play important roles in cardiovascular homeostasis via activation of guanylate cyclase-linked receptors, we used mice lacking natriuretic peptide receptor (NPR)-A (NPR1) to establish if natriuretic peptides contribute to the cardiovascular dysfunction present in endotoxic shock. Wild-type (WT) and NPR-A knockout (KO) mice were exposed to lipopolysaccharide (LPS) and vascular dysfunction (in vitro and in vivo), production of pro-inflammatory cytokines, and iNOS expression and activity were evaluated. LPS-treated WT animals exhibited a marked fall in mean arterial blood pressure (MABP) whereas NPR-A KO mice maintained MABP throughout. LPS administration caused a greater suppression of vascular responses to the thromboxane-mimetic U46619, ANP, acetylcholine and ...Continue Reading

References

Nov 1, 1991·Annals of Surgery·J B OchoaA B Peitzman
Nov 15, 1990·Biochemical and Biophysical Research Communications·R G KilbournR F Lodato
Jan 1, 1994·Cardiovascular Research·A PetrosP Vallance
Nov 1, 1994·Journal of Leukocyte Biology·Q Xie, C Nathan
Jan 1, 1997·Annual Review of Immunology·J MacMickingC Nathan
Feb 7, 1998·Proceedings of the National Academy of Sciences of the United States of America·P M OliverN Maeda
Jul 1, 1998·British Journal of Pharmacology·D D ReesS Moncada
Nov 11, 1999·British Journal of Pharmacology·M B HussainR J MacAllister
Feb 22, 2001·American Journal of Physiology. Renal Physiology·D Pérez-SalaS Lamas
Jan 10, 2003·The New England Journal of Medicine·Richard S Hotchkiss, Irene E Karl
Feb 15, 2003·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·S D ChauhanA Ahluwalia
Feb 14, 2004·Basic Research in Cardiology·Amrita AhluwaliaAdrian J Hobbs
Dec 16, 2004·Critical Care Medicine·Henning D StubbeFrank Hinder
Jun 4, 2005·Arteriosclerosis, Thrombosis, and Vascular Biology·C A GunnettD D Heistad
Mar 18, 2006·Critical Care : the Official Journal of the Critical Care Forum·Mervyn Singer
Oct 4, 2006·British Journal of Pharmacology·M MadhaniR J MacAllister
May 2, 2008·British Journal of Pharmacology·S P H AlexanderJ A Peters

❮ Previous
Next ❯

Citations

Jan 15, 2011·Journal of Leukocyte Biology·David A WinkCarol A Colton
Aug 2, 2011·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·Na JiangFenghua Fu

❮ Previous
Next ❯

Methods Mentioned

BETA
ELISA

Software Mentioned

PowerLab
GraphPad
GraphPad Prism

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.